POINT-OF-CARE COAGULATION TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-22051 | Pharmaceuticals
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Point-of-Care Coagulation Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET
7.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA POINT-OF-CARE COAGULATION TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Getein Biotech, Inc.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Siemens Healthcare
16.3 ILine Microsystems
16.4 Diagon
16.5 Abbott Laboratories
16.6 Accriva Diagnostics
16.7 Alere
16.8 TaiDoc Technology Corporation
16.9 Callegari Srl
16.10 Goldsite Diagnostics Inc
16.11 F.Hoffmann-La Roche
16.12 CoaquSense
16.13 Medtronic
16.14 Sysmex
16.15 Micropoint Bioscience
16.16 Helena Point of Care
16.17 HemoSonics
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Most important types of Point-of-Care Coagulation Testing products covered in this report are:Prothrombin Time/International Normalized Tatio (PT-INR) Testing
Bleeding Time Testing
Fibrinogen Level Testing
Others
Most widely used downstream fields of Point-of-Care Coagulation Testing market covered in this report are:
Retail Prices
Hospitals
Clinics
Health Centers
Homecare Settings
Companies
Getein Biotech, Inc.
Siemens Healthcare
ILine Microsystems
Diagon
Abbott Laboratories
Accriva Diagnostics
Alere
TaiDoc Technology Corporation
Callegari Srl
Goldsite Diagnostics Inc
F.Hoffmann-La Roche
CoaquSense
Medtronic
Sysmex
Micropoint Bioscience
Helena Point of Care
HemoSonics
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.